With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
The Conservative leader and her media supporters used a new study as evidence to support her plan to increase drilling in the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果